AEROVATE THERAPEUTICS INC (AVTE) Stock Cash Flow
NASDAQ:AVTE - Nasdaq - US0080641071 - Common Stock - Currency: USD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -84.61M | -75.52M | -51.51M | -22.96M | -9.61M | |||
| Depreciation Amortization | 300.00K | 96.00K | 70.00K | 20.00K | 0.00 | |||
| Change In Working Capital | -1.11M | 9.80M | 7.76M | -6.51M | 970.00K | |||
| Other non cash items | 10.46M | 8.85M | 4.57M | 2.06M | 780.00K | |||
| OPERATING CASH FLOW | -74.95M | -56.78M | -39.12M | -27.40M | -7.86M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -142.00K | -200.00K | -180.00K | N/A | |||
| Other Investing Activity | 48.61M | 12.02M | 7.12M | -113.25M | N/A | |||
| INVESTING CASH FLOW | 48.55M | 11.88M | 6.93M | -113.43M | N/A | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | 0.00 | |||
| Stock Issued/Repurchased | 25.64M | 46.23M | 770.00K | 190.46M | 8.92M | |||
| Other Financing Activity | -311.00K | -234.00K | -370.00K | N/A | N/A | |||
| FINANCING CASH FLOW | 25.34M | 46.00M | 400.00K | 190.46M | 8.92M | |||
| CHANGE IN CASH | -1.06M | 1.09M | -31.79M | 49.63M | 1.06M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -74.95M | -56.78M | -39.12M | -27.40M | -7.86M | |||
| Capital Expenditure | N/A | -142.00K | -200.00K | -180.00K | N/A | |||
| FREE CASH FLOW | -75.01M | -56.92M | -39.32M | -27.58M | -7.86M | |||
All data in USD